» Articles » PMID: 37110255

Cervicovaginal Microbiota Profiles in Precancerous Lesions and Cervical Cancer Among Ethiopian Women

Abstract

Although high-risk human papillomavirus infection is a well-established risk factor for cervical cancer, other co-factors within the local microenvironment may play an important role in the development of cervical cancer. The current study aimed to characterize the cervicovaginal microbiota in women with premalignant dysplasia or invasive cervical cancer compared with that of healthy women. The study comprised 120 Ethiopian women (60 cervical cancer patients who had not received any treatment, 25 patients with premalignant dysplasia, and 35 healthy women). Cervicovaginal specimens were collected using either an Isohelix DNA buccal swab or an Evalyn brush, and ribosomal RNA sequencing was used to characterize the cervicovaginal microbiota. Shannon and Simpson diversity indices were used to evaluate alpha diversity. Beta diversity was examined using principal coordinate analysis of weighted UniFrac distances. Alpha diversity was significantly higher in patients with cervical cancer than in patients with dysplasia and in healthy women ( < 0.01). Beta diversity was also significantly different in cervical cancer patients compared with the other groups (weighted UniFrac Bray-Curtis, < 0.01). Microbiota composition differed between the dysplasia and cervical cancer groups. was particularly enriched in patients with cancer, and a high relative abundance of species was identified in the dysplasia and healthy groups, whereas , , , and species predominated in the cervical cancer group. In summary, we identified differences in cervicovaginal microbiota diversity, composition, and relative abundance between women with cervical cancer, women with dysplasia, and healthy women. Additional studies need to be carried out in Ethiopia and other regions to control for variation in sample collection.

Citing Articles

Associations of the gut, cervical, and vaginal microbiota with cervical cancer: a systematic review and meta-analysis.

Wen Q, Wang S, Min Y, Liu X, Fang J, Lang J BMC Womens Health. 2025; 25(1):65.

PMID: 39955550 PMC: 11829412. DOI: 10.1186/s12905-025-03599-1.


Diagnostic and prognostic potential of the intra-tumoral microbiota profile in HPV-independent endocervical adenocarcinoma.

Zhou X, Chen L, Lin W, Zheng W, Zhang H, Zhou F Front Cell Infect Microbiol. 2024; 14:1440017.

PMID: 39220287 PMC: 11362085. DOI: 10.3389/fcimb.2024.1440017.


Analysis of the correlation between cervical HPV infection, cervical lesions and vaginal microecology.

Fan Z, Han D, Fan X, Zeng Y, Zhao L Front Cell Infect Microbiol. 2024; 14:1405789.

PMID: 39220285 PMC: 11362039. DOI: 10.3389/fcimb.2024.1405789.


Human Papillomavirus Infections and the Role Played by Cervical and Cervico-Vaginal Microbiota-Evidence from Next-Generation Sequencing Studies.

Glowienka-Stodolak M, Baginska-Drabiuk K, Szubert S, Hennig E, Horala A, Dabrowska M Cancers (Basel). 2024; 16(2).

PMID: 38254888 PMC: 10814012. DOI: 10.3390/cancers16020399.


Association of Oral Microbiome With Oral Human Papillomavirus Infection: A Population Study of the National Health and Nutrition Examination Survey, 2009-2012.

Feng X, Patel E, White J, Li S, Zhu X, Zhao N J Infect Dis. 2024; 230(3):726-735.

PMID: 38181070 PMC: 11420769. DOI: 10.1093/infdis/jiae004.


References
1.
Aldunate M, Srbinovski D, Hearps A, Latham C, Ramsland P, Gugasyan R . Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis. Front Physiol. 2015; 6:164. PMC: 4451362. DOI: 10.3389/fphys.2015.00164. View

2.
Wu S, Ding X, Kong Y, Acharya S, Wu H, Huang C . The feature of cervical microbiota associated with the progression of cervical cancer among reproductive females. Gynecol Oncol. 2021; 163(2):348-357. DOI: 10.1016/j.ygyno.2021.08.016. View

3.
Dareng E, Ma B, Adebamowo S, Famooto A, Ravel J, Pharoah P . Vaginal microbiota diversity and paucity of Lactobacillus species are associated with persistent hrHPV infection in HIV negative but not in HIV positive women. Sci Rep. 2020; 10(1):19095. PMC: 7644686. DOI: 10.1038/s41598-020-76003-7. View

4.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

5.
Pyeon D, Pearce S, Lank S, Ahlquist P, Lambert P . Establishment of human papillomavirus infection requires cell cycle progression. PLoS Pathog. 2009; 5(2):e1000318. PMC: 2642596. DOI: 10.1371/journal.ppat.1000318. View